Explore top tech companies
All Filters
Location

Office Type

Industry

Size

Open Jobs

Remote Jobs

Perks

DEI

Tech Stack

Top Biotech Companies (3,709)

Superluminal Medicines, Inc.
Boston
24 Employees
Hiring Now

Superluminal Medicines is a Boston-based generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created. Our platform creates candidate-ready compounds with unprecedented speed using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure. The predict-design-test architecture accurately models protein shapes and designs highly selective...

• •
• •
Superluminal Medicines, Inc.
Elite Clinical Network
Biotech • Pharmaceutical
5 Offices
57 Employees
Hiring Now

With 30+ years of experience, 28+ locations, and 2,000+ clinical studies conducted, Elite Clinical Network (ECN) is a trusted leader in clinical research. Our dedicated network of research sites is built on personalized service, investigator diversity, and rigorous quality processes to ensure excellence in every study. Backed by a professional corporate management team, we partner with top physicians across diverse specialties...

• •
• •
Elite Clinical Network
Topos Bio
Artificial Intelligence • Healthtech • Biotech • Pharmaceutical
United States
Hiring Now

Topos Bio is an AI-powered biotechnology company developing therapies for intrinsically disordered proteins (IDPs) by creating an AI-native drug discovery platform that models protein ensembles to tackle previously undruggable targets.

• •
• •
Topos Bio
Aroa Biosurgery Limited
Healthtech • Biotech • Manufacturing
2 Offices
247 Employees
Hiring Now

Aroa Biosurgery is a soft-tissue regeneration company that develops, manufactures, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Committed to 'unlocking regenerative healing for everybody,' the company leverages its proprietary AROA ECM™ technology—a novel extracellular matrix biomaterial derived from ovine forestomach—to create regenerative tissue substitutes that significantly improve patient outcomes.

• •
• •
Aroa Biosurgery Limited
Annexon Biosciences
Healthtech • Biotech • Pharmaceutical
South San Francisco
81 Employees
Hiring Now

Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. The company’s pipeline is based on its platform technology addressing a broad spectrum of well-researched classical complement-mediated autoimmune and neurodegenerative diseases triggered by aberrant activation of C1q, the initiating...

• •
• •
Annexon Biosciences
Countable Labs
Oakland
48 Employees
Hiring Now
Meet the only PCR method that counts, Countable PCR—your precision genomics system for no fuss single-molecule counting

In an era of ever-increasing cost and skills required to do complex diagnostics tests, Countable Labs (formerly Enumerix) is developing a next-generation genomics platform to make high resolution biology simple, fast, and affordable. Our goal is to reduce the cost of high resolution tests by at least 10 times to enable access to a broader patient population. We believe our...

• •
• •
Countable Labs
Sarepta Therapeutics
4 Offices
1,464 Employees
29 Benefits Hiring Now

Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is...

• •
• •
Sarepta Therapeutics

Sarepta Therapeutics's Top Stability & Growth Strengths

Strong Market Position & Advantage: Elevidys achieved first-to-market status in U.S. DMD gene therapy and secured a conditional approval in Japan, giving Sarepta unmatched commercial scale versus DMD-focused peers while Pfizer’s Phase 3 failure reduced near-term rivalry. Feedback suggests Sarepta is treated as the incumbent in DMD genetic medicines based on availability and footprint.

Diversified Revenue Streams: Beyond Elevidys, Sarepta continues to generate substantial sales from exon-skipping PMOs and also receives ex‑U.S. royalties, creating multiple revenue sources within DMD. This mix supported strong 2024–2025 revenues even as gene therapy dynamics evolved.

Strategic Partnerships: The Roche/Chugai alliance expands ex‑U.S. access, contributed royalties, and enabled Japan approval, supporting global reach. This complements Sarepta’s in‑house Elevidys manufacturing to scale distribution.

Clear Labs
Cloud • Software • Analytics • Biotech
San Carlos
112 Employees
22 Benefits Hiring Now

Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics and cloud-based analytics, Clear Labs democratizes genomics applications to deliver increased clarity. Clear Labs’ turnkey platform accelerates outcomes and improves accuracy - from food-borne pathogens to infectious diseases, including SARS...

• •
• •
Clear Labs
Scripps Research
3 Offices
1,944 Employees
23 Benefits Hiring Now

Scripps Research is a leader in the discovery and application of biomedical breakthroughs that improve human health. As the world's largest independent non-profit biomedical research facility, we expand the frontiers of science and education and create hope for millions. Scripps Research is ranked #1 for innovation by the Nature Index.

• •
• •
Scripps Research
Let Your Resume Do The Work
Upload your resume to be matched with jobs you're a great fit for.

Trans Ova
Biotech • Agriculture
Sioux Center
383 Employees
Hiring Now

Trans Ova Genetics is a livestock reproductive technology company that helps producers accelerate genetic progress and improve herd genetics. Its services include embryo transfer, in vitro fertilization (IVF), sexed semen, genetic preservation, cloning, donor housing, export, and recipient options. The company serves dairy and beef cattle, small ruminants, and swine, and operates as part of the URUS Group. Its mission...

• •
• •
Trans Ova
Alphazyme
Biotech
Jupiter
26 Employees
2 Benefits Hiring Now

Alphazyme was founded in 2018 by Christopher Benoit, Stephana Petrino and Chad Decker. Our experienced team has a track record of success and a passion for supporting molecular biology innovators. Our mission is to be the world’s premier partner for custom, industrial-scale, molecular biology enzymes. We are enzyme development and production experts, and partner with the manufacturers of nucleic acid therapies and...

• •
• •
Alphazyme
QIAGEN
Biotech
18 Offices
6,000 Employees
21 Benefits Hiring Now

QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to...

• •
• •
QIAGEN

QIAGEN's Top Stability & Growth Strengths

Strong Market Position & Advantage: Leadership in latent TB blood testing (QuantiFERON) and entrenched sample‑preparation technologies is reinforced by global guidelines and deep workflow stickiness. The company is also building share in digital PCR and competes credibly in syndromic panels despite strong incumbents.

Resilient & Sustainable Growth: Net sales grew in 2025 with guidance for further mid‑single‑digit growth in 2026, and earnings are guided to improve. Growth is increasingly driven by non‑COVID ‘pillars’ with recurring consumables and software that generally support steadier demand.

Future-Ready Strategy: Management pruned non‑core lines (e.g., NeuMoDx exit) and refocused investment on five growth pillars with multi‑year targets through 2028. Ongoing menu expansions, regulatory submissions, and targeted M&A (e.g., single‑cell and clinical genomics software) indicate continued positioning for scaled, profitable growth.

Gossamer Bio
Healthtech • Biotech
2 Offices
200 Employees
1 Benefits Hiring Now

Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with...

• •
• •
Gossamer Bio
Valthos
Artificial Intelligence • Biotech • Defense
New York
10 Employees
Hiring Now

We develop frontier AI systems that identify biological threats and design medical countermeasures in real time. We're assembling exceptional people to join us in this mission. Our founding team comes from Palantir, DeepMind, the Broad Institute, and the Arc Institute, and we're actively hiring. We are grateful for the support of our investors including OpenAI, Lux Capital, Founders Fund, and more.

• •
• •
Valthos
Africa Health Research Institute (AHRI)
Healthtech • Social Impact • Biotech
South Africa
490 Employees
Hiring Now

Africa Health Research Institute (AHRI) is an independent, transdisciplinary scientific research institute based across two campuses in KwaZulu-Natal, South Africa. It combines population, basic and translational, social, and clinical sciences to understand and improve community health, with a strong focus on HIV, tuberculosis, and related diseases. AHRI partners with communities and global institutions while training the next generation of African...

• •
• •
Africa Health Research Institute (AHRI)
Massachusetts College of Pharmacy and Health Sciences
Edtech • Healthtech • Biotech • Pharmaceutical
3 Offices
Hiring Now

Massachusetts College of Pharmacy and Health Sciences (MCPHS) is an innovator in health and professional education, preparing future generations of global leaders to improve public health. With over 7,000 students across campuses in Boston, Worcester, and Manchester, MCPHS is one of the largest and most highly-ranked institutions for health and life sciences, dedicated to advancing the healthcare landscape through education...

• •
• •
Massachusetts College of Pharmacy and Health Sciences
AQEMIA
Healthtech • Biotech
2 Offices
64 Employees
Hiring Now

AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology. Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data. We already delivered several drug discovery successes within our...

• •
• •
AQEMIA
Healios K.K.
Biotech
2 Offices
470 Employees
Hiring Now

Healios K.K. is a leading Japanese clinical-stage biotechnology company specializing in regenerative medicine and cell therapy, developing innovative treatments for life-threatening conditions.

• •
• •
Healios K.K.
Roche
Healthtech • Biotech • Pharmaceutical
12 Offices
93,797 Employees
48 Benefits Hiring Now

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with...

• •
• •
Roche

Roche's Top Stability & Growth Strengths

Strong Market Position & Advantage: Roche is the global leader in in‑vitro diagnostics and remains a top‑tier biopharma with a significant oncology footprint. The dual Pharmaceuticals–Diagnostics model is a strategic differentiator at scale.

Strong Revenue Growth: Group sales rose 7% at constant exchange rates in 2025 and 6% at CER in Q1 2026, with both divisions contributing. Guidance for 2026 indicates continued mid–single‑digit CER growth.

Profitability: Profitability improved in 2025 alongside sales, with higher IFRS net income and core EPS growth. Management pointed to capacity to keep investing while rewarding shareholders.

Gerresheimer
Healthtech • Biotech • Pharmaceutical
34 Offices
2,246 Employees
1 Benefits Hiring Now

Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence, focus on quality and customers....

• •
• •
Gerresheimer

• •

• •

• •

• •

Sign in to save company job alert.

Create Free Account